Difference between revisions of "Template:Lipid modifying agents"
Jump to navigation
Jump to search
imported>Rudolf Virchow m (fixed typo ("colestyramine" -> "cholestyramine")) |
|||
| Line 2: | Line 2: | ||
| name = Lipid modifying agents | | name = Lipid modifying agents | ||
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | | title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | ||
| − | | groupstyle = | + | | groupstyle = backg |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}} | }} | ||
Revision as of 00:14, 19 February 2009
| group2 = Liver
| list2 = Template:Navbox subgroup
| group4 = Blood vessels | list4 = Template:Navbox subgroup
| group7 = Combinations
| list7 = Niacin/lovastatinTemplate:• Niacin/simvastatinTemplate:• Ezetimibe/simvastatin
| group8 = Other | list8 = DextrothyroxineTemplate:• ProbucolTemplate:• TiadenolTemplate:• BenfluorexTemplate:• MeglutolTemplate:• Omega-3-triglyceridesTemplate:• Magnesium pyridoxal 5-phosphate glutamateTemplate:• PolicosanolTemplate:• Lapaquistat§Template:• Alipogene tiparvovec
| list9 = †Undergoing clinical trials. ‡Withdrawn from market. §Development terminated. # = WHO-EM }}